INTERNATIONAL CONGRESS ON ADVANCES IN MEDICAL THERAPY IN CARDIOLOGY #TYR0119BZ2009

Finalità

Acute coronary syndrome, atrial fibrillation, dyslipidaemias and advanced heart failure are medical problems increasingly absorbing a significant amount of resources all over the world and their treatment is rapidly evolving.
Aside to the intensified resort to mechanic revascularisations procedures (i.e. percutaneous coronary intervention), and to electrophisiological ablation procedures, many antiplatelet, anticoagulant and lipid lowering drugs have been developed in the last years. The new agents offer great opportunities in patients' treatment, but their use is still conflicting in the different settings. Furthermore, doctors encounter daily clinical situations, where the use of these drugs are not clearly codified and remains uncertain.
Recently an increased attention to out of hospital treatment of chronic heart failure has been promoted in order to reduce rehospitalisations. Guidelines have been repeatedly updated and should be continuosly explained in detail in order to facilitate its application in daily clinical practice.
Antiplatelet, anticoagulant, lipid lowering and heart failure therapies play a central role in modern cardiology and proper knowledge of their indication should be part of every physician's expertise.